United Health Products Q3: $5,588 Cash, Going Concern, and Not Enough Authorized Shares
UEEC sits 61% above its 52-week low of $0.029 on light trading volume (0.1× avg).
Summary
United Health Products reported $5,588 of cash, negative working capital of $4.24 million and a going-concern warning, with authorized shares insufficient to cover potential note conversions and RSUs. Nearly all convertible notes mature December 31, 2026, and the company has no funds to repay them.
Key Events · Earnings and Guidance · UEEC
-
Going Concern Reaffirmed on Thin Cash
Cash was $5,588 at September 30, 2026, down from $65,249 at December 31, 2025, with negative working capital of $4,244,045 and no revenue.
-
Authorized Shares Fall Short of Obligations
Only 36,314,412 shares remain authorized, versus roughly 77,757,961 issuable on convertible notes and warrants plus 40,315,000 RSUs; the company warns of potential defaults and an inability to raise equity until authorized shares are increased.
-
Convertible Notes Mature December 31, 2026
Substantially all convertible notes, including $500,000 of related-party notes, mature December 31, 2026, and the company states it does not have the funds to repay them.
-
Prior Periods Revised for Unrecorded Invoices
$108,521 of vendor invoices went unrecorded ($14,915 in 2024, $93,606 in 2025), revising accumulated deficit and prior-period expenses; disclosure controls were concluded not effective.
Analysis · UEEC · Industrial Applications And Services
Cash stood at just $5,588 on September 30 against $4.27 million of current liabilities, and management again flags substantial doubt about the company's ability to continue as a going concern. The binding constraint, however, is structural: only 36,314,412 authorized shares remain, versus roughly 77.8 million issuable on convertible notes and warrants plus 40.3 million RSUs. Until shareholders approve more authorized shares, the company may breach its note obligations and be unable to raise equity under the Alumni AMPA. Substantially all convertible notes mature December 31, 2026, and there is no cash to repay them. The filing also revises prior periods for $108,521 of unrecorded vendor invoices and concludes that disclosure controls were not effective.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UEEC was trading at $0.05 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $12.1M. The 52-week trading range was $0.03 to $0.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.